Pleth Variability Index in Pulmonary Embolism
Key facts
- Who runs it
- Suleyman Demirel University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1 person enrolled
- Started
- 1 Apr 2023
- Ended
- 1 Jun 2024
- Type of study
- Observational
- Treatments tested
- Masimo Radical-7® Pulse CO-Oximeter
- Record updated
- 18 July 2024
Who can take part
- Age
- 18 years to 93 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- To be over 18 years old
- Diagnosis of pulmonary embolism
Who cannot take part
- patients had asthma and chronic obstructive pulmonary disease exacerbation
- patients had acute decompensated heart failure
- patient was under 18 years old
- patients were pregnant
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pulmonary embolism(PE) is a ventilation/perfusion disorder caused by obstruction of the pulmonary artery, usually by a thrombus. The Pleth Variability Index(PVI) is a continuous, noninvasive indicator of dynamic perfusion index changes in photoplethysmography that occur in at least one respiratory cycle. The aim of this study is to evaluate the prognostic and mortality indicator role of PVI in patients with PE, hypothesizing that PVI could serve as a valuable guide in this disease where perfusion impairment is fundamental.
Read full original descriptionShow less
Based on our study, we determined that PVI could be a non-invasive, rapid, and objective tool for predicting disease progression and mortality in PE patients in the emergency department. Our study is the first to evaluate the PVI in PE.
The group in the trial
- patients diagnosed pulmonary embolism
Patients over the age of 18 who presented to the emergency department of a tertiary care hospital with complaints of cough, dyspnea, chest pain, tachycardia, hemoptysis, and syncope, and were diagnosed with pulmonary embolism (PE) confirmed by pulmonary computed tomographic angiography (CTPA), were included in our study. Informed consent was obtained from the patients who were stable and from the relatives of the patients who were unstable. Plethysmographic variability index (PVI) and Perfusion index (PI) levels were automatically obtained 2 minutes after the device was attached, using a probe placed on the index finger of the hand while the patient was lying supine. PI and PVI measurements and data were collected consecutively by the same individual. The measurements were taken using the Masimo Radical-7® Pulse CO-Oximeter, which is approved by the U.S. Food and Drug Administration.
Treatment: Masimo Radical-7® Pulse CO-Oximeter
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pleth Variability Index: A Potential New Marker for Predicting the Mortality of Pulmonary Embolism?
- Publications
- Plethysmographic measurements as novel predictors of mortality in pulmonary embolism.BMC pulmonary medicine, 2026
- Record updated
- 18 July 2024